Cardiovascular implications of osmotic changes during hemodialysis: a potential risk factor
International Urology and Nephrology · 2025
DOI: 10.1007/s11255-025-04817-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urology and Nephrology, 2025. Verfasst von Kamila Bołtuć-Dziugieł und 6 weiteren Autor:innen. Beteiligte Einrichtung: Collegium Medicum, Jan Kochanowski University, 25-317, Kielce, Poland. kbdziugiel@gmail.com. Hauptthemen laut MEDLINE: Renal Dialysis, Kidney Failure, Chronic, Osmotic Pressure, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jan Kochanowski University, Kielce, Poland.
Abstract (Originalsprache)
PURPOSE: End-stage renal disease (ESRD) patients undergoing hemodialysis (HD) face a significantly higher risk of cardiovascular-related mortality compared to the general population. Osmotic stress, defined as the strain caused by rapid shifts in plasma solute concentration, occurs during HD and places additional burden on the cardiovascular system. Our study aimed to assess the effect of this HD-induced osmotic stress on cardiovascular parameters. METHODS: A total of 46 ESRD patients treated with HD were included in the study. For each patient, plasma osmolality, blood pressure, digital electrocardiography, and subendocardial viability ratio (SEVR) were measured before and after a single HD session. RESULTS: Plasma osmolality decreased by 18.59 mOsm/kg (5.8%) after a single HD session (p < 0.0001), reflecting HD-related osmotic stress. A prolongation of the corrected QT (QTc) interval by 8.0 ms (p = 0.0001) and an improvement in SEVR by 14.5% (p = 0.0004) were also observed. Changes in plasma osmolality correlated with alterations in QTc interval (r = 0.434, p = 0.005), urea (r = 0.461, p = 0.002), and SEVR (r = - 0.439, p = 0.004), among others. Multiple regression analysis identified osmolality change as an independent predictor of SEVR and QTc interval changes. Interestingly, changes in urea were not significant, possibly due to urea rebound or other osmotic factors. CONCLUSION: Our study revealed that changes in plasma osmolality are reliable predictors of the QTc interval and SEVR. Interestingly, changes in urea were not significant, possibly due to the phenomenon of "urea rebound" or the influence of other osmotic factors. Hemodialysis-related osmotic changes appear to affect cardiovascular parameters, potentially predisposing patients to cardiac events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collegium Medicum, Jan Kochanowski University, 25-317, Kielce, Poland. kbdziugiel@gmail.com.
- Collegium Medicum, Jan Kochanowski University, 25-317, Kielce, Poland.
- Ophthalmology Clinic, Voivodeship Regional Hospital, 25-736, Kielce, Poland.
- Department of Surgical Medicine with the Laboratory of Medical Genetics, Collegium Medicum, Jan Kochanowski University, 25-317, Kielce, Poland.
- First Department of Anesthesiology and Intensive Care, University Hospital No. 4, 20-090, Lublin, Poland.
Förderung
- Jan Kochanowski University, Kielce, Poland
Zitieren
APA
Bołtuć-Dziugieł, K., Dziugieł, R., Roskal-Wałek, J., Bociek, A., Terpiłowska, S., Dąbrowski, W., & Jaroszyński, A. (2025). Cardiovascular implications of osmotic changes during hemodialysis: a potential risk factor. International Urology and Nephrology. https://doi.org/10.1007/s11255-025-04817-3
Vancouver
Bołtuć-Dziugieł K, Dziugieł R, Roskal-Wałek J, Bociek A, Terpiłowska S, Dąbrowski W, et al. Cardiovascular implications of osmotic changes during hemodialysis: a potential risk factor. International Urology and Nephrology. 2025. doi:10.1007/s11255-025-04817-3
BibTeX
@article{BotuDziugie2025,
author = {Bołtuć-Dziugieł, Kamila and Dziugieł, Robert and Roskal-Wałek, Joanna and Bociek, Agnieszka and Terpiłowska, Sylwia and Dąbrowski, Wojciech and Jaroszyński, Andrzej},
title = {Cardiovascular implications of osmotic changes during hemodialysis: a potential risk factor},
journal = {International Urology and Nephrology},
year = {2025},
doi = {10.1007/s11255-025-04817-3}
}
EUVIMED